Neos Therapeutics, Inc. Debt to Equity Ratio 2015-2020 | NEOS
Current and historical debt to equity ratio values for Neos Therapeutics, Inc. (NEOS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Neos Therapeutics, Inc. debt/equity for the three months ending September 30, 2020 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-09-30 | $0.09B | $-0.02B | -4.14 |
| 2020-06-30 | $0.08B | $-0.02B | -4.88 |
| 2020-03-31 | $0.10B | $-0.01B | -7.76 |
| 2019-12-31 | $0.10B | $-0.01B | -15.82 |
| 2019-09-30 | $0.10B | $-0.00B | -31.30 |
| 2019-06-30 | $0.09B | $-0.00B | -56.37 |
| 2019-03-31 | $0.10B | $0.00B | 89.51 |
| 2018-12-31 | $0.10B | $0.01B | 13.20 |
| 2018-09-30 | $0.10B | $-0.03B | -3.75 |
| 2018-06-30 | $0.10B | $-0.02B | -5.51 |
| 2018-03-31 | $0.10B | $-0.01B | -22.54 |
| 2017-12-31 | $0.10B | $0.01B | 10.64 |
| 2017-09-30 | $0.10B | $0.02B | 6.70 |
| 2017-06-30 | $0.09B | $0.03B | 3.68 |
| 2017-03-31 | $0.09B | $0.01B | 6.85 |
| 2016-12-31 | $0.08B | $-0.00B | -52.77 |
| 2016-09-30 | $0.08B | $0.02B | 5.13 |
| 2016-06-30 | $0.08B | $0.04B | 1.89 |
| 2016-03-31 | $0.05B | $0.07B | 0.77 |
| 2015-12-31 | $0.04B | $0.08B | 0.56 |
| 2015-09-30 | $0.04B | $0.09B | 0.51 |
| 2015-06-30 | $0.05B | $0.01B | 3.97 |
| 2015-03-31 | $0.04B | $0.02B | 2.45 |
| 2014-12-31 | $0.03B | $0.01B | 2.98 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
